Cannabis Law Report

SEPTEMBER 6, 2021

For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. Similarly, it is also used in combination with traditional opioid painkillers, which enables patients to reduce the dosage and frequency of opioids significantly and imparts greater pain relief. Key Topics Covered: 1 Preface.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

The Cannigma

MARCH 7, 2022

When CBN was studied without barbiturates (prescription sedative medications typically used for epilepsy), the combination of CBN and THC produced greater sedation together than either cannabinoid alone. What can the current clinical trials tell us? Common cannabinoids in cannabis.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

Canna Care Docs

DECEMBER 16, 2020

Medical cannabis is available in any of the same forms as recreational cannabis—as smokable flower, edibles , tinctures, topical products , and more. Another highly effective use of medical cannabis is for nausea and vomiting, particularly for cancer patients undergoing chemotherapy. Chronic pain. Multiple sclerosis.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

The Joint Blog

APRIL 22, 2022

There are multiple ways to ingest this oil; one can apply it topically, consume it through smoke inhalation or in the form of edible. Consumption of CBD through smoke inhalation or ingestion is beneficial for treating widespread pain, while topical application is recommended for alleviating pain from a specific area. Treats Epilepsy.

Oil 26

Oil CBD Topical Clinical Trials 26

CannaTech

SEPTEMBER 16, 2018

Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Shedding Stigma and Promoting Patient Access.

Education 66

Education Medicine Clinical Trials Patients 66

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

Ultimately, cannabis for mental health seems to boil down to questions of individual patient suitability. CBD is also available in conventional pill and tablet form, as a base to use for cooking, and in topical products. It’s also possible for altered states to have healing or beneficial effects on others.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

More than half the states in the country have now legalized medical cannabis for patients with qualifying conditions and several more have gone so far as to legalize recreational marijuana for adults. Cannabis Legalization Throughout The Country. The recent years have seen drastic marijuana law changes in several states.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Greencamp

AUGUST 16, 2018

Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Kind Meds (Cannabis Education Blog)

NOVEMBER 16, 2022

capsule, oil, topical, edible). Here are some of the most common effects CBN may have on patients: Wound Healing and Anti-Inflammatory Properties. When CBN cream is applied to the skin of clinical trial participants, it appears to be beneficial in treating epidermolysis bullosa, a rare disease that causes blisters on the skin.

Sleep 94

Sleep Cannabinoids THC CBD 94

Cannabis Law Report

FEBRUARY 3, 2022

Patients suffering from chronic diseases, like Parkinson’s, Alzheimer’s, cancer, and many neurological disorders, are administered cannabis. Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. Clinical Trials of Cannabis Are Still on Going. 2564 (2021).

Indica 52

Indica Oil Legalization Research and Development 52

The Cannigma

JUNE 15, 2021

Some healthcare professionals are already encouraged by what is known, much of it anecdotal accounts from patients in their practices. The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

JANUARY 24, 2022

where marijuana for recreational use has been legalized, the market has witnessed a dynamic shift of patients from traditional methods or medicine to opting to use marijuana for medical and other purposes. Key Topics Covered: Chapter 1 Methodology and Scope. North America Legal Cannabis Number of clinical trials.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

DECEMBER 20, 2021

First Patient Expected to be Enrolled by Q2 of 2022. Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., BERWYN, Pa.–(BUSINESS About Altasciences.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

SEPTEMBER 20, 2021

Nanomerics”) to use Nanomeric’s molecular envelope platform technology (MET) for the nasal delivery of a cannabidiol (CBD) for the management of epilepsy in adults and children. Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Epilepsy Behav. Available at: www.fda.gov/media/131878/download.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

MGC Pharma

FEBRUARY 20, 2018

Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

DECEMBER 28, 2021

We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Epoladerm™ Epoladerm is a diclofenac topical spray film product candidate that is being developed for pain associated with osteoarthritis of the knee. to conduct this study in Canada.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Key Topics Covered: Chapter 1 Methodology and Scope. Legal Cannabis Market Report Highlights. Market Segmentation.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

NOVEMBER 15, 2021

Finally, we recently acquired the worldwide rights to VRP324, which is an intranasal pharmaceutical-grade cannabidiol product candidate for the management of epilepsy in children (rare pediatric disease) and adults. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 10, 2021

“We are encouraged with the progress that has been made under the CRADA with NCATS and the NIH Helping to End Addiction Long-term (HEAL) initiative, as we believe that it may help Virpax develop an effective and safe alternative to conventional opioids used by patients to manage acute and chronic pain. Forward-Looking Statement.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

DECEMBER 22, 2021

It doesn’t mean, necessarily, that the market should go to full legalization within a year or two, because it won’t happen so fast, but you can have more patients with other medical indications that were not given cannabis before. Obviously, that means that there are more patients and there are more products to sell.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. the form the finished product can take (edibles, topicals, etc.). how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40